About this Website

Comparison of Female Viagra and Male Viagra

Female Viagra, also known as Flibanserin or Addyi, is fundamentally different from the male version of the drug. Male Viagra is taken on an as-needed basis before engaging in sexual activity, whereas female Viagra is designed to be taken daily before bedtime. Female Viagra aims to address hypoactive sexual desire disorder (HSDD), rather than enhancing a physical response.

The Role of the FDA in Drug Approval

The U.S. Food and Drug Administration (FDA) approved Flibanserin, ensuring its safety and efficacy for treating HSDD in premenopausal women. The drug underwent rigorous testing and met the standards set by the FDA for approval.

Understanding Hypoactive Sexual Desire Disorder (HSDD)

HSDD is a condition characterized by a decrease in sexual desire, leading to distress or interpersonal difficulties. It is not merely a "mechanical issue," but a complex interplay of psychological, relational, and hormonal factors. Flibanserin is designed to help address this by modifying certain neurotransmitters in the brain associated with sexual desire.

Target Group for Female Viagra: Premenopausal Women

The primary target demographic for female Viagra is premenopausal women suffering from HSDD. This condition can significantly affect their quality of life, relationships, and overall well-being.

The Dosage and Usage Instructions for Female Viagra

Unlike male Viagra, which is taken when desired, female Viagra must be taken daily before bedtime.

It is not intended for occasional or on-demand use.

Moreover, it does not act immediately after ingestion like its male counterpart.

Time Frame: How Long Female Viagra Takes to Work

The time frame for female Viagra to begin working is not immediate. On average, it takes about four weeks for any noticeable effects to start, with peak effects not seen until around eight weeks. It is essential to note that it may not work for all women, as individual responses can vary.

Clinical Trials and Results: Data from Sprout Pharmaceuticals

Clinical trials conducted by Sprout Pharmaceuticals found an increase in sexually satisfying events in women who took Flibanserin for at least eight weeks compared to those taking a placebo. The participants reported an 80% increase in sexual desire and 58% more satisfaction during sexual activity.

The Placebo Effect in the Context of Female Viagra Trials

As with any medication, the placebo effect plays a role in clinical trials. This phenomenon involves participants reporting improved symptoms due to their belief in the treatment rather than the treatment's actual effect.

Other Options: Bremelanotide (Vyleesi)

Apart from Flibanserin, another option is Bremelanotide (Vyleesi), which is taken as a shot in the belly or thigh 45 minutes before sexual intercourse. Similar to Flibanserin, it is only recommended to take one shot in a 24-hour period.

Other Noteworthy Facts

It's essential to understand that female Viagra might cause side effects such as dizziness, nausea, tiredness, and difficulty falling asleep. Viagra, when used in women, is thought to raise blood flow to the genitals, increasing sensitivity and stimulation. It may provide a benefit for women having difficulty with sexual arousal, as it can enhance their response to sexual stimulation.